Announcements

A Form 4 filed on August 21, 2026, disclosed that Joseph T. Noonan, a director of Watts Water Technologies Inc (NYSE:WTS), reported a conversion of Class B Common Stock into Class A Common Stock on August 20, 2026, with shares held indirectly through a …

Paul C. Raymond, a director at Calumet, Inc. /DE (NASDAQ:CLMT), filed a Form 4 on August 21, 2026, reporting the acquisition of two tranches of Restricted Stock Units with a transaction date of August 20, 2026.

Timothy P. Horne, a director at Watts Water Technologies Inc (NYSE:WTS), filed a Form 4 on August 21, 2026, reporting a disposition of 3,650 shares of Class B Common Stock on August 20, 2026, via transaction code G.

A Form 4 filed with the SEC on August 21, 2026, discloses that Emily Rollins, a director of Xometry, Inc. (NASDAQ:XMTR), exercised a stock option and sold a total of 5,000 shares of Class A Common Stock on August 19, 2026, pursuant to a …

Kevin McCulloch, President and Chief Operating Officer of Xeris Biopharma Holdings, Inc. (NASDAQ:XERS), filed a statement of changes in beneficial ownership on August 21, 2026, disclosing a share disposition on August 1, 2026 related to the net settlement of vested restricted stock units.

A Form 4 filed on August 21, 2026, reports that Randolph Altschuler, a director of Xometry, Inc. (NASDAQ:XMTR), transferred 85,582 shares of Class A Common Stock on August 20, 2026, through the 2021 Tigers Trust for no consideration.

John Patrick Shannon Jr., Chief Executive Officer and Chairman of the Board of Xeris Biopharma Holdings, Inc., disclosed a change in beneficial ownership of common stock on August 21, 2026, reflecting a tax-withholding transaction tied to restricted stock unit vesting.